Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will have a significant presence at the upcoming Cantor Global Healthcare Conference. The company’s management team is scheduled to participate in a fireside chat on September 4, 2025, at 14:10 ET in New York City. This event offers a platform for the company to engage with investors and discuss its ongoing initiatives in the field of rare neurological diseases.
The session will be accessible via a live webcast on the company’s investor relations page, allowing stakeholders to follow the conversation in real-time. An on-demand replay will also be available after the event for those unable to attend live.
Harmony Biosciences, headquartered in Plymouth Meeting, Pennsylvania, is dedicated to developing and commercializing innovative therapies aimed at addressing the needs of patients suffering from rare neurological conditions. Since its founding in 2017, the company has focused on advancing treatments that enhance the quality of life for underserved patient communities.
The participation in this prominent healthcare conference underscores Harmony’s commitment to transparency and communication with the investment community. With a growing focus on rare diseases, the company aims to highlight its strategies and progress in bringing vital therapies to market.
For more information on the event and to access the live webcast, interested parties can visit the company’s official investor relations website.
